| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 5 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | WIPO (World Intellectual Property Organization) | 5 | |
| #4 | Canada | 4 | |
| #5 | China | 4 | |
| #6 | Israel | 4 | |
| #7 | United States | 4 | |
| #8 | South Africa | 4 | |
| #9 | United Kingdom | 2 | |
| #10 | Republic of Korea | 1 | |
| #11 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals | |
| #3 | Environmental technology | |
| #4 | Medical technology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Morand Eric Francis | 29 |
| #2 | Iskander Magdy Naguib | 22 |
| #3 | Skene Colin Edward | 13 |
| #4 | Danylec Basil | 11 |
| #5 | Tapley Peter Mark | 7 |
| #6 | Jozefiak Thomas H | 7 |
| #7 | Francis Morand Eric | 6 |
| #8 | Li Xinhua | 6 |
| #9 | Naguib Iskander Magdy | 4 |
| #10 | Edward Skene Colin | 3 |
| Publication | Filing date | Title |
|---|---|---|
| AU2006326850A1 | MIF inhibitors | |
| WO2005058304A1 | Implantable device containing inhibitor of macrophage migration inhibitory factor | |
| WO2004089927A1 | Novel methods for the treatment of inflammatory diseases | |
| CN1675154A | Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF) | |
| CN101675927A | therapeutic molecules and methods-1 |